

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | adenosine receptor signaling pathway (GO:0001973) | 4.65583585 |
| 2 | regulation of platelet activation (GO:0010543) | 4.31283850 |
| 3 | thrombin receptor signaling pathway (GO:0070493) | 4.21625561 |
| 4 | regulation of platelet aggregation (GO:0090330) | 4.19021760 |
| 5 | amino acid import (GO:0043090) | 4.18974823 |
| 6 | cyclooxygenase pathway (GO:0019371) | 3.90588855 |
| 7 | lipoxygenase pathway (GO:0019372) | 3.89757275 |
| 8 | negative regulation of platelet activation (GO:0010544) | 3.89751279 |
| 9 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.88446710 |
| 10 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.87046020 |
| 11 | platelet aggregation (GO:0070527) | 3.75589810 |
| 12 | granulocyte activation (GO:0036230) | 3.72999537 |
| 13 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.72312869 |
| 14 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.72312869 |
| 15 | modulation by symbiont of host immune response (GO:0052553) | 3.72312869 |
| 16 | positive regulation by symbiont of host defense response (GO:0052509) | 3.72312869 |
| 17 | modulation by symbiont of host defense response (GO:0052031) | 3.72312869 |
| 18 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.72312869 |
| 19 | angiogenesis involved in wound healing (GO:0060055) | 3.59694338 |
| 20 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.55680291 |
| 21 | neutrophil activation (GO:0042119) | 3.51663429 |
| 22 | layer formation in cerebral cortex (GO:0021819) | 3.50477123 |
| 23 | positive regulation of macrophage differentiation (GO:0045651) | 3.47761860 |
| 24 | positive regulation of mast cell activation (GO:0033005) | 3.47192324 |
| 25 | positive regulation of vasculogenesis (GO:2001214) | 3.43739621 |
| 26 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.42904196 |
| 27 | response to methylmercury (GO:0051597) | 3.41995120 |
| 28 | endothelium development (GO:0003158) | 3.40577325 |
| 29 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.40541353 |
| 30 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.37122035 |
| 31 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.33035754 |
| 32 | axon ensheathment in central nervous system (GO:0032291) | 3.30357306 |
| 33 | central nervous system myelination (GO:0022010) | 3.30357306 |
| 34 | regulation of integrin activation (GO:0033623) | 3.29264421 |
| 35 | response to peptidoglycan (GO:0032494) | 3.28261769 |
| 36 | L-amino acid import (GO:0043092) | 3.25939808 |
| 37 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.20464970 |
| 38 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.18428944 |
| 39 | platelet degranulation (GO:0002576) | 3.17216187 |
| 40 | regulation of mast cell degranulation (GO:0043304) | 3.14730577 |
| 41 | sodium-independent organic anion transport (GO:0043252) | 3.13688991 |
| 42 | positive regulation of receptor recycling (GO:0001921) | 3.12510532 |
| 43 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.09161752 |
| 44 | regulation of vasculogenesis (GO:2001212) | 3.06917072 |
| 45 | regulation of early endosome to late endosome transport (GO:2000641) | 3.06728709 |
| 46 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.03432012 |
| 47 | tolerance induction (GO:0002507) | 3.02578975 |
| 48 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.02062725 |
| 49 | regulation of homotypic cell-cell adhesion (GO:0034110) | 2.97792395 |
| 50 | cellular response to cholesterol (GO:0071397) | 2.96440147 |
| 51 | positive regulation of p38MAPK cascade (GO:1900745) | 2.95087011 |
| 52 | low-density lipoprotein particle remodeling (GO:0034374) | 2.94245312 |
| 53 | regulation of podosome assembly (GO:0071801) | 2.93838222 |
| 54 | creatine metabolic process (GO:0006600) | 2.93340695 |
| 55 | erythrocyte maturation (GO:0043249) | 2.92686379 |
| 56 | serine transport (GO:0032329) | 2.91467716 |
| 57 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.90444486 |
| 58 | regulation of leukocyte degranulation (GO:0043300) | 2.90261176 |
| 59 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.89925557 |
| 60 | L-serine transport (GO:0015825) | 2.86653635 |
| 61 | microglial cell activation (GO:0001774) | 2.86306333 |
| 62 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.85808065 |
| 63 | positive regulation of astrocyte differentiation (GO:0048711) | 2.85729798 |
| 64 | negative regulation of lipid storage (GO:0010888) | 2.84745210 |
| 65 | leukocyte aggregation (GO:0070486) | 2.84620858 |
| 66 | mesodermal cell differentiation (GO:0048333) | 2.84098117 |
| 67 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.83441200 |
| 68 | positive regulation of mast cell degranulation (GO:0043306) | 2.83441200 |
| 69 | regulation of p38MAPK cascade (GO:1900744) | 2.82834015 |
| 70 | Notch signaling involved in heart development (GO:0061314) | 2.82578873 |
| 71 | regulation of somitogenesis (GO:0014807) | 2.81203229 |
| 72 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.79939845 |
| 73 | lymph vessel development (GO:0001945) | 2.79491275 |
| 74 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.78940619 |
| 75 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.78210052 |
| 76 | negative regulation of focal adhesion assembly (GO:0051895) | 2.77890368 |
| 77 | negative regulation of cell junction assembly (GO:1901889) | 2.77890368 |
| 78 | negative regulation of adherens junction organization (GO:1903392) | 2.77890368 |
| 79 | regulation of memory T cell differentiation (GO:0043380) | 2.77683311 |
| 80 | negative regulation of interleukin-12 production (GO:0032695) | 2.75819976 |
| 81 | regulation of vitamin metabolic process (GO:0030656) | 2.75559341 |
| 82 | protein localization to endosome (GO:0036010) | 2.74887853 |
| 83 | blood coagulation, intrinsic pathway (GO:0007597) | 2.74793348 |
| 84 | platelet activation (GO:0030168) | 2.73977980 |
| 85 | response to laminar fluid shear stress (GO:0034616) | 2.72374057 |
| 86 | response to magnesium ion (GO:0032026) | 2.70183804 |
| 87 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.70070068 |
| 88 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.69899451 |
| 89 | homotypic cell-cell adhesion (GO:0034109) | 2.69800249 |
| 90 | positive regulation of leukocyte degranulation (GO:0043302) | 2.68903292 |
| 91 | neutral amino acid transport (GO:0015804) | 2.68465640 |
| 92 | cellular response to sterol (GO:0036315) | 2.68180193 |
| 93 | regulation of mononuclear cell migration (GO:0071675) | 2.66673688 |
| 94 | modulation by symbiont of host cellular process (GO:0044068) | 2.66605048 |
| 95 | regulation of mast cell activation (GO:0033003) | 2.66573172 |
| 96 | macrophage activation involved in immune response (GO:0002281) | 2.66009556 |
| 97 | cellular response to arsenic-containing substance (GO:0071243) | 2.65508714 |
| 98 | positive regulation of interleukin-17 production (GO:0032740) | 2.65273798 |
| 99 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.64975016 |
| 100 | positive regulation of blood coagulation (GO:0030194) | 2.64880180 |
| 101 | positive regulation of hemostasis (GO:1900048) | 2.64880180 |
| 102 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.64808712 |
| 103 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.64675380 |
| 104 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.64643134 |
| 105 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.64017250 |
| 106 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.63973211 |
| 107 | stress fiber assembly (GO:0043149) | 2.63840808 |
| 108 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.63374781 |
| 109 | regulation of chronic inflammatory response (GO:0002676) | 2.62087608 |
| 110 | endothelial cell differentiation (GO:0045446) | 2.61598982 |
| 111 | protein neddylation (GO:0045116) | 2.61354631 |
| 112 | membrane invagination (GO:0010324) | 2.61143117 |
| 113 | decidualization (GO:0046697) | 2.60598928 |
| 114 | glycosphingolipid catabolic process (GO:0046479) | 2.59618110 |
| 115 | positive regulation of coagulation (GO:0050820) | 2.58690400 |
| 116 | phagocytosis, engulfment (GO:0006911) | 2.58659837 |
| 117 | signal complex assembly (GO:0007172) | 2.58179112 |
| 118 | import into cell (GO:0098657) | 2.58105518 |
| 119 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.57508810 |
| 120 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.54468124 |
| 121 | negative regulation of interleukin-10 production (GO:0032693) | 2.54078827 |
| 122 | response to muramyl dipeptide (GO:0032495) | 2.51430108 |
| 123 | response to cholesterol (GO:0070723) | 2.51294172 |
| 124 | heme biosynthetic process (GO:0006783) | 2.50859000 |
| 125 | response to thyroid hormone (GO:0097066) | 2.49227660 |
| 126 | ensheathment of neurons (GO:0007272) | 2.48998793 |
| 127 | axon ensheathment (GO:0008366) | 2.48998793 |
| 128 | purinergic receptor signaling pathway (GO:0035587) | 2.48811954 |
| 129 | regulation of sensory perception (GO:0051931) | 2.47883801 |
| 130 | regulation of sensory perception of pain (GO:0051930) | 2.47883801 |
| 131 | peptide catabolic process (GO:0043171) | 2.47221599 |
| 132 | myeloid cell activation involved in immune response (GO:0002275) | 2.47130291 |
| 133 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.47125529 |
| 134 | germ cell migration (GO:0008354) | 2.47100809 |
| 135 | hemoglobin metabolic process (GO:0020027) | 2.46882957 |
| 136 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.46691586 |
| 137 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.46462016 |
| 138 | cortical actin cytoskeleton organization (GO:0030866) | 2.46219795 |
| 139 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.44405986 |
| 140 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.43953876 |
| 141 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.43796783 |
| 142 | negative regulation of interleukin-17 production (GO:0032700) | 2.42704413 |
| 143 | regulation of mitochondrial depolarization (GO:0051900) | 2.42516417 |
| 144 | adhesion of symbiont to host cell (GO:0044650) | 2.39977528 |
| 145 | virion attachment to host cell (GO:0019062) | 2.39977528 |
| 146 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.39797614 |
| 147 | regulation of cholesterol efflux (GO:0010874) | 2.39743330 |
| 148 | regulation of receptor recycling (GO:0001919) | 2.39206938 |
| 149 | regulation of activation of Janus kinase activity (GO:0010533) | 2.39015280 |
| 150 | protein kinase B signaling (GO:0043491) | 2.38894293 |
| 151 | myelination (GO:0042552) | 2.38878377 |
| 152 | positive regulation of systemic arterial blood pressure (GO:0003084) | 2.38353761 |
| 153 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.37889543 |
| 154 | response to sterol (GO:0036314) | 2.37523678 |
| 155 | T-helper 1 type immune response (GO:0042088) | 2.35878388 |
| 156 | negative regulation of norepinephrine secretion (GO:0010700) | 2.35643222 |
| 157 | regulation of norepinephrine secretion (GO:0014061) | 2.35391945 |
| 158 | fibrinolysis (GO:0042730) | 2.35101784 |
| 159 | modulation by virus of host process (GO:0019054) | 2.34708027 |
| 160 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.33899754 |
| 161 | response to host immune response (GO:0052572) | 2.33898071 |
| 162 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.33898071 |
| 163 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.33532719 |
| 164 | cortical cytoskeleton organization (GO:0030865) | 2.33007408 |
| 165 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.32419760 |
| 166 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.31611767 |
| 167 | positive regulation of type 2 immune response (GO:0002830) | 2.31532828 |
| 168 | nucleotide transmembrane transport (GO:1901679) | 2.30058203 |
| 169 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.29845750 |
| 170 | cellular extravasation (GO:0045123) | 2.28577559 |
| 171 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.27163930 |
| 172 | neutrophil activation involved in immune response (GO:0002283) | 2.27127254 |
| 173 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.27036675 |
| 174 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.26985304 |
| 175 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.26876496 |
| 176 | response to host (GO:0075136) | 2.26876496 |
| 177 | response to host defenses (GO:0052200) | 2.26876496 |
| 178 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.26860477 |
| 179 | hemidesmosome assembly (GO:0031581) | 2.26201915 |
| 180 | keratan sulfate biosynthetic process (GO:0018146) | 2.26063582 |
| 181 | myeloid cell development (GO:0061515) | 2.25772445 |
| 182 | response to lead ion (GO:0010288) | 2.23956603 |
| 183 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.22250513 |
| 184 | response to lipoprotein particle (GO:0055094) | 2.21773272 |
| 185 | blood vessel maturation (GO:0001955) | 2.21753880 |
| 186 | protein targeting to plasma membrane (GO:0072661) | 2.21159213 |
| 187 | trabecula morphogenesis (GO:0061383) | 2.19380980 |
| 188 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.18215171 |
| 189 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.17591690 |
| 190 | regulation of interleukin-17 production (GO:0032660) | 2.16347252 |
| 191 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.16051027 |
| 192 | cell adhesion mediated by integrin (GO:0033627) | 2.15857121 |
| 193 | iron ion import (GO:0097286) | 2.15822366 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.26027460 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.99370067 |
| 3 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.97632071 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.88163838 |
| 5 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.87776255 |
| 6 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.82908030 |
| 7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.78527694 |
| 8 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.70262620 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.63873848 |
| 10 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.50969319 |
| 11 | GATA1_19941826_ChIP-Seq_K562_Human | 2.47671099 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.25624689 |
| 13 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.23203563 |
| 14 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.15664229 |
| 15 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.06867633 |
| 16 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.05516878 |
| 17 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.02745865 |
| 18 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.98857321 |
| 19 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.95963532 |
| 20 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.93632039 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.92727220 |
| 22 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88391728 |
| 23 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.87537683 |
| 24 | KDM2B_26808549_Chip-Seq_K562_Human | 1.86216226 |
| 25 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.85306733 |
| 26 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.82230022 |
| 27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.80734927 |
| 28 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.79780940 |
| 29 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.78131506 |
| 30 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.74209251 |
| 31 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.73514270 |
| 32 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.72885709 |
| 33 | GATA2_19941826_ChIP-Seq_K562_Human | 1.60832433 |
| 34 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.60780341 |
| 35 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.56582866 |
| 36 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.55915641 |
| 37 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.55399824 |
| 38 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.52363835 |
| 39 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.52119648 |
| 40 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.49215494 |
| 41 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.47929971 |
| 42 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.47178319 |
| 43 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.44761786 |
| 44 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.44411578 |
| 45 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.43657122 |
| 46 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.42513061 |
| 47 | MAF_26560356_Chip-Seq_TH1_Human | 1.41326360 |
| 48 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.41256237 |
| 49 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.40071190 |
| 50 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.39800185 |
| 51 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.39259248 |
| 52 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.39039400 |
| 53 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.38300371 |
| 54 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.38300371 |
| 55 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.38300371 |
| 56 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.37394417 |
| 57 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.35868755 |
| 58 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.35818159 |
| 59 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.34421471 |
| 60 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.33844488 |
| 61 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.33711483 |
| 62 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.33300932 |
| 63 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32318322 |
| 64 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.31210746 |
| 65 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.30552851 |
| 66 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.29693993 |
| 67 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.29500424 |
| 68 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.27559667 |
| 69 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.25372236 |
| 70 | * KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.24644959 |
| 71 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.24202166 |
| 72 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.23340174 |
| 73 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.20786645 |
| 74 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.19858793 |
| 75 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.19850748 |
| 76 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19553045 |
| 77 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.19359617 |
| 78 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.18484153 |
| 79 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.18437510 |
| 80 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18314538 |
| 81 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16787134 |
| 82 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.16428375 |
| 83 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.16133974 |
| 84 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.15507488 |
| 85 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.15163605 |
| 86 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.14974878 |
| 87 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.14856032 |
| 88 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.14710578 |
| 89 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.14050357 |
| 90 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13949571 |
| 91 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.13809604 |
| 92 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.13177813 |
| 93 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.12535794 |
| 94 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.12435366 |
| 95 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.11548991 |
| 96 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.10979169 |
| 97 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09831279 |
| 98 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.09090056 |
| 99 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.07875721 |
| 100 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.07220576 |
| 101 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.07000930 |
| 102 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.06641736 |
| 103 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06516821 |
| 104 | SPI1_23127762_ChIP-Seq_K562_Human | 1.06109848 |
| 105 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.05926539 |
| 106 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05835960 |
| 107 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.05734355 |
| 108 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05432463 |
| 109 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.05335275 |
| 110 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04529955 |
| 111 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.03977497 |
| 112 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.03611779 |
| 113 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.02674777 |
| 114 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02297196 |
| 115 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.02048607 |
| 116 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.01890711 |
| 117 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.01698415 |
| 118 | * WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.01556101 |
| 119 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.00945198 |
| 120 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00657504 |
| 121 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00432687 |
| 122 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.99946413 |
| 123 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.99894206 |
| 124 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.99834409 |
| 125 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.99834409 |
| 126 | UTX_26944678_Chip-Seq_JUKART_Human | 0.98864572 |
| 127 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.98084392 |
| 128 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.97311990 |
| 129 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.96908267 |
| 130 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.96733562 |
| 131 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.96619532 |
| 132 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.95389224 |
| 133 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.94347815 |
| 134 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.94045362 |
| 135 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.93705277 |
| 136 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.92783803 |
| 137 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.92569045 |
| 138 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.92359357 |
| 139 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.91953232 |
| 140 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.91181926 |
| 141 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.91090224 |
| 142 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.89911280 |
| 143 | * PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.88250654 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003656_abnormal_erythrocyte_physiolo | 4.23130942 |
| 2 | MP0008004_abnormal_stomach_pH | 4.09679442 |
| 3 | MP0003303_peritoneal_inflammation | 3.18529373 |
| 4 | MP0005167_abnormal_blood-brain_barrier | 2.90792994 |
| 5 | MP0004147_increased_porphyrin_level | 2.60888090 |
| 6 | MP0005623_abnormal_meninges_morphology | 2.59159680 |
| 7 | MP0009278_abnormal_bone_marrow | 2.43043832 |
| 8 | MP0005171_absent_coat_pigmentation | 2.34309410 |
| 9 | MP0000685_abnormal_immune_system | 2.21092169 |
| 10 | MP0003690_abnormal_glial_cell | 2.11467728 |
| 11 | MP0000920_abnormal_myelination | 2.09453231 |
| 12 | MP0003724_increased_susceptibility_to | 2.01129621 |
| 13 | MP0003436_decreased_susceptibility_to | 1.97421415 |
| 14 | MP0003453_abnormal_keratinocyte_physiol | 1.95657459 |
| 15 | MP0003300_gastrointestinal_ulcer | 1.94328690 |
| 16 | MP0003075_altered_response_to | 1.91070099 |
| 17 | MP0000343_altered_response_to | 1.87328191 |
| 18 | MP0000465_gastrointestinal_hemorrhage | 1.81506137 |
| 19 | MP0004272_abnormal_basement_membrane | 1.75518659 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 1.73372526 |
| 21 | MP0009785_altered_susceptibility_to | 1.71060734 |
| 22 | MP0002405_respiratory_system_inflammati | 1.68307266 |
| 23 | MP0002139_abnormal_hepatobiliary_system | 1.65341058 |
| 24 | MP0001879_abnormal_lymphatic_vessel | 1.64942079 |
| 25 | MP0002419_abnormal_innate_immunity | 1.64255098 |
| 26 | MP0001835_abnormal_antigen_presentation | 1.64192483 |
| 27 | MP0005000_abnormal_immune_tolerance | 1.62640414 |
| 28 | MP0005165_increased_susceptibility_to | 1.61950649 |
| 29 | MP0003828_pulmonary_edema | 1.60282723 |
| 30 | MP0001533_abnormal_skeleton_physiology | 1.60213864 |
| 31 | MP0000858_altered_metastatic_potential | 1.58094759 |
| 32 | MP0005058_abnormal_lysosome_morphology | 1.57862827 |
| 33 | MP0004858_abnormal_nervous_system | 1.56186226 |
| 34 | MP0008260_abnormal_autophagy | 1.53601006 |
| 35 | MP0004510_myositis | 1.52717053 |
| 36 | MP0006082_CNS_inflammation | 1.51695827 |
| 37 | MP0002332_abnormal_exercise_endurance | 1.46625311 |
| 38 | MP0006054_spinal_hemorrhage | 1.45169226 |
| 39 | MP0005025_abnormal_response_to | 1.42000682 |
| 40 | MP0001849_ear_inflammation | 1.39435172 |
| 41 | MP0005387_immune_system_phenotype | 1.38686850 |
| 42 | MP0001790_abnormal_immune_system | 1.38686850 |
| 43 | MP0005083_abnormal_biliary_tract | 1.37050421 |
| 44 | MP0000733_abnormal_muscle_development | 1.36486916 |
| 45 | MP0003091_abnormal_cell_migration | 1.35738020 |
| 46 | MP0002148_abnormal_hypersensitivity_rea | 1.34023792 |
| 47 | MP0004947_skin_inflammation | 1.33582358 |
| 48 | MP0004145_abnormal_muscle_electrophysio | 1.32805619 |
| 49 | MP0002933_joint_inflammation | 1.31663314 |
| 50 | MP0003634_abnormal_glial_cell | 1.31522832 |
| 51 | MP0002998_abnormal_bone_remodeling | 1.28004535 |
| 52 | MP0008874_decreased_physiological_sensi | 1.25521789 |
| 53 | MP0003879_abnormal_hair_cell | 1.23171089 |
| 54 | MP0000749_muscle_degeneration | 1.22093426 |
| 55 | MP0010678_abnormal_skin_adnexa | 1.22068836 |
| 56 | MP0003172_abnormal_lysosome_physiology | 1.21525797 |
| 57 | MP0000747_muscle_weakness | 1.20473914 |
| 58 | MP0002736_abnormal_nociception_after | 1.20207010 |
| 59 | MP0001851_eye_inflammation | 1.20086244 |
| 60 | MP0005671_abnormal_response_to | 1.19305461 |
| 61 | MP0000604_amyloidosis | 1.18455068 |
| 62 | MP0003566_abnormal_cell_adhesion | 1.18057355 |
| 63 | MP0002452_abnormal_antigen_presenting | 1.17379858 |
| 64 | MP0003329_amyloid_beta_deposits | 1.17175169 |
| 65 | MP0001545_abnormal_hematopoietic_system | 1.16452901 |
| 66 | MP0005397_hematopoietic_system_phenotyp | 1.16452901 |
| 67 | MP0005164_abnormal_response_to | 1.16106682 |
| 68 | MP0002723_abnormal_immune_serum | 1.12533042 |
| 69 | MP0010155_abnormal_intestine_physiology | 1.11302776 |
| 70 | MP0001819_abnormal_immune_cell | 1.09752485 |
| 71 | MP0003279_aneurysm | 1.08723787 |
| 72 | MP0002420_abnormal_adaptive_immunity | 1.08622039 |
| 73 | MP0009763_increased_sensitivity_to | 1.07023784 |
| 74 | MP0009764_decreased_sensitivity_to | 1.06433231 |
| 75 | MP0000383_abnormal_hair_follicle | 1.04161967 |
| 76 | MP0005390_skeleton_phenotype | 1.03652129 |
| 77 | MP0009840_abnormal_foam_cell | 1.00326943 |
| 78 | MP0009765_abnormal_xenobiotic_induced | 0.99925200 |
| 79 | MP0005451_abnormal_body_composition | 0.99301130 |
| 80 | MP0005464_abnormal_platelet_physiology | 0.98889873 |
| 81 | MP0001663_abnormal_digestive_system | 0.98515871 |
| 82 | MP0003448_altered_tumor_morphology | 0.97636207 |
| 83 | MP0002282_abnormal_trachea_morphology | 0.96472848 |
| 84 | MP0009333_abnormal_splenocyte_physiolog | 0.94564035 |
| 85 | MP0004484_altered_response_of | 0.94534834 |
| 86 | MP0001542_abnormal_bone_strength | 0.92709759 |
| 87 | MP0002877_abnormal_melanocyte_morpholog | 0.92656656 |
| 88 | MP0001853_heart_inflammation | 0.92647596 |
| 89 | MP0000230_abnormal_systemic_arterial | 0.92448943 |
| 90 | MP0008469_abnormal_protein_level | 0.92244567 |
| 91 | MP0002254_reproductive_system_inflammat | 0.91720593 |
| 92 | MP0000750_abnormal_muscle_regeneration | 0.90601013 |
| 93 | MP0002295_abnormal_pulmonary_circulatio | 0.90473823 |
| 94 | MP0005076_abnormal_cell_differentiation | 0.89358051 |
| 95 | MP0003136_yellow_coat_color | 0.86843587 |
| 96 | MP0001958_emphysema | 0.86247846 |
| 97 | MP0001800_abnormal_humoral_immune | 0.86124540 |
| 98 | MP0000249_abnormal_blood_vessel | 0.85250078 |
| 99 | MP0003045_fibrosis | 0.84308870 |
| 100 | MP0002106_abnormal_muscle_physiology | 0.83997633 |
| 101 | MP0003638_abnormal_response/metabolism_ | 0.82940627 |
| 102 | MP0003705_abnormal_hypodermis_morpholog | 0.82783700 |
| 103 | MP0005166_decreased_susceptibility_to | 0.82401510 |
| 104 | MP0001346_abnormal_lacrimal_gland | 0.82224936 |
| 105 | MP0005365_abnormal_bile_salt | 0.82158459 |
| 106 | MP0004130_abnormal_muscle_cell | 0.81958837 |
| 107 | MP0004185_abnormal_adipocyte_glucose | 0.81843814 |
| 108 | MP0005410_abnormal_fertilization | 0.81213560 |
| 109 | MP0008438_abnormal_cutaneous_collagen | 0.80369114 |
| 110 | MP0010234_abnormal_vibrissa_follicle | 0.80281567 |
| 111 | MP0003186_abnormal_redox_activity | 0.80204438 |
| 112 | MP0002398_abnormal_bone_marrow | 0.80190909 |
| 113 | MP0005595_abnormal_vascular_smooth | 0.79460120 |
| 114 | MP0003633_abnormal_nervous_system | 0.79297034 |
| 115 | MP0000759_abnormal_skeletal_muscle | 0.79052959 |
| 116 | MP0000767_abnormal_smooth_muscle | 0.78914660 |
| 117 | MP0004885_abnormal_endolymph | 0.78754881 |
| 118 | MP0003795_abnormal_bone_structure | 0.78514564 |
| 119 | MP0005023_abnormal_wound_healing | 0.78472072 |
| 120 | MP0008569_lethality_at_weaning | 0.78197231 |
| 121 | MP0001299_abnormal_eye_distance/ | 0.78186933 |
| 122 | MP0002733_abnormal_thermal_nociception | 0.77785005 |
| 123 | MP0001845_abnormal_inflammatory_respons | 0.77744813 |
| 124 | MP0005620_abnormal_muscle_contractility | 0.76330419 |
| 125 | MP0003646_muscle_fatigue | 0.76212942 |
| 126 | MP0002429_abnormal_blood_cell | 0.73826554 |
| 127 | MP0005310_abnormal_salivary_gland | 0.73183122 |
| 128 | MP0001968_abnormal_touch/_nociception | 0.71877709 |
| 129 | MP0000716_abnormal_immune_system | 0.71160784 |
| 130 | MP0001970_abnormal_pain_threshold | 0.69475472 |
| 131 | MP0005666_abnormal_adipose_tissue | 0.65686472 |
| 132 | MP0002089_abnormal_postnatal_growth/wei | 0.61904218 |
| 133 | MP0005381_digestive/alimentary_phenotyp | 0.60574598 |
| 134 | MP0004883_abnormal_blood_vessel | 0.59426142 |
| 135 | MP0005501_abnormal_skin_physiology | 0.59180350 |
| 136 | MP0002653_abnormal_ependyma_morphology | 0.58332372 |
| 137 | MP0001915_intracranial_hemorrhage | 0.58166122 |
| 138 | MP0002722_abnormal_immune_system | 0.56722342 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Petechiae (HP:0000967) | 7.51186604 |
| 2 | Prolonged bleeding time (HP:0003010) | 7.42774332 |
| 3 | Purpura (HP:0000979) | 7.17714248 |
| 4 | Menorrhagia (HP:0000132) | 6.94472039 |
| 5 | Increased mean platelet volume (HP:0011877) | 6.77583532 |
| 6 | Abnormal platelet volume (HP:0011876) | 6.44133834 |
| 7 | Exercise-induced muscle cramps (HP:0003710) | 6.00466992 |
| 8 | Epistaxis (HP:0000421) | 5.42271723 |
| 9 | Gingival bleeding (HP:0000225) | 4.73492436 |
| 10 | Abnormal platelet function (HP:0011869) | 4.27397052 |
| 11 | Impaired platelet aggregation (HP:0003540) | 4.27397052 |
| 12 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.11289971 |
| 13 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.11289971 |
| 14 | Abnormality of glycolipid metabolism (HP:0010969) | 4.11289971 |
| 15 | Paralysis (HP:0003470) | 3.77332978 |
| 16 | Round ear (HP:0100830) | 3.57477200 |
| 17 | Abnormality of binocular vision (HP:0011514) | 3.48312432 |
| 18 | Diplopia (HP:0000651) | 3.48312432 |
| 19 | Onycholysis (HP:0001806) | 3.36400651 |
| 20 | Vacuolated lymphocytes (HP:0001922) | 3.29804839 |
| 21 | Muscle stiffness (HP:0003552) | 3.22549305 |
| 22 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.20499848 |
| 23 | Spontaneous hematomas (HP:0007420) | 3.17252403 |
| 24 | Exercise-induced myalgia (HP:0003738) | 3.06312470 |
| 25 | Conjunctival telangiectasia (HP:0000524) | 2.95405911 |
| 26 | Reticulocytosis (HP:0001923) | 2.92366920 |
| 27 | Hyperlipoproteinemia (HP:0010980) | 2.91312987 |
| 28 | Hepatosplenomegaly (HP:0001433) | 2.87422511 |
| 29 | Increased serum ferritin (HP:0003281) | 2.86396836 |
| 30 | Neurofibrillary tangles (HP:0002185) | 2.83819237 |
| 31 | Pustule (HP:0200039) | 2.83647283 |
| 32 | Eczematoid dermatitis (HP:0000976) | 2.82383495 |
| 33 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.78998515 |
| 34 | Diaphragmatic weakness (HP:0009113) | 2.77117271 |
| 35 | Systemic lupus erythematosus (HP:0002725) | 2.73664790 |
| 36 | Abnormality of the common coagulation pathway (HP:0010990) | 2.72012527 |
| 37 | Thick nail (HP:0001805) | 2.71427493 |
| 38 | Difficulty running (HP:0009046) | 2.71374614 |
| 39 | Milia (HP:0001056) | 2.70017694 |
| 40 | Loss of speech (HP:0002371) | 2.66507430 |
| 41 | Recurrent abscess formation (HP:0002722) | 2.63927870 |
| 42 | Bruising susceptibility (HP:0000978) | 2.62429237 |
| 43 | Poikilocytosis (HP:0004447) | 2.60358608 |
| 44 | Polycythemia (HP:0001901) | 2.59703914 |
| 45 | Myocardial infarction (HP:0001658) | 2.59412663 |
| 46 | Increased cerebral lipofuscin (HP:0011813) | 2.58996110 |
| 47 | Amyloidosis (HP:0011034) | 2.55600166 |
| 48 | Nuclear cataract (HP:0100018) | 2.54263536 |
| 49 | Muscle fiber inclusion bodies (HP:0100299) | 2.54133438 |
| 50 | Orchitis (HP:0100796) | 2.52564823 |
| 51 | Myositis (HP:0100614) | 2.52007195 |
| 52 | Abnormality of iron homeostasis (HP:0011031) | 2.49990920 |
| 53 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.48851707 |
| 54 | Stomatitis (HP:0010280) | 2.45516137 |
| 55 | Abnormality of lateral ventricle (HP:0030047) | 2.44159761 |
| 56 | Dysostosis multiplex (HP:0000943) | 2.44089219 |
| 57 | Optic neuritis (HP:0100653) | 2.42356271 |
| 58 | Retrobulbar optic neuritis (HP:0100654) | 2.42356271 |
| 59 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.42023776 |
| 60 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.39539502 |
| 61 | Mutism (HP:0002300) | 2.38656118 |
| 62 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.35705658 |
| 63 | Premature rupture of membranes (HP:0001788) | 2.35340859 |
| 64 | Epiphyseal dysplasia (HP:0002656) | 2.35248127 |
| 65 | Arterial tortuosity (HP:0005116) | 2.29039892 |
| 66 | Choroideremia (HP:0001139) | 2.28600334 |
| 67 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.27065247 |
| 68 | Atrophic scars (HP:0001075) | 2.26944945 |
| 69 | Hypoplasia of the iris (HP:0007676) | 2.25551946 |
| 70 | Episodic fever (HP:0001954) | 2.25237154 |
| 71 | Cerebral inclusion bodies (HP:0100314) | 2.22715957 |
| 72 | Disinhibition (HP:0000734) | 2.21651717 |
| 73 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.20668517 |
| 74 | Hypoplastic ischia (HP:0003175) | 2.19701775 |
| 75 | Abnormality of proline metabolism (HP:0010907) | 2.18464317 |
| 76 | Hydroxyprolinuria (HP:0003080) | 2.18464317 |
| 77 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.17686222 |
| 78 | Myopathic facies (HP:0002058) | 2.17293085 |
| 79 | Upper limb muscle weakness (HP:0003484) | 2.15729546 |
| 80 | Prolonged neonatal jaundice (HP:0006579) | 2.15407237 |
| 81 | Abnormality of the Achilles tendon (HP:0005109) | 2.15056888 |
| 82 | Hemiparesis (HP:0001269) | 2.14877384 |
| 83 | Calcaneovalgus deformity (HP:0001848) | 2.14274493 |
| 84 | Nemaline bodies (HP:0003798) | 2.13934375 |
| 85 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.13533386 |
| 86 | Aplasia of the phalanges of the hand (HP:0009802) | 2.13533386 |
| 87 | Aplasia involving bones of the extremities (HP:0009825) | 2.13533386 |
| 88 | Acanthocytosis (HP:0001927) | 2.12818400 |
| 89 | Distal lower limb amyotrophy (HP:0008944) | 2.12431072 |
| 90 | Xanthomatosis (HP:0000991) | 2.11590039 |
| 91 | Peripheral hypomyelination (HP:0007182) | 2.10397128 |
| 92 | Distal arthrogryposis (HP:0005684) | 2.08764867 |
| 93 | Chronic obstructive pulmonary disease (HP:0006510) | 2.08245140 |
| 94 | Obstructive lung disease (HP:0006536) | 2.08245140 |
| 95 | Increased IgM level (HP:0003496) | 2.07634657 |
| 96 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.07077000 |
| 97 | Premature skin wrinkling (HP:0100678) | 2.03608036 |
| 98 | Vascular tortuosity (HP:0004948) | 2.03323881 |
| 99 | Abnormality of the ischium (HP:0003174) | 2.03142936 |
| 100 | Type 1 muscle fiber predominance (HP:0003803) | 2.01972951 |
| 101 | Apathy (HP:0000741) | 2.00790855 |
| 102 | Muscle fiber splitting (HP:0003555) | 2.00174899 |
| 103 | Neuronal loss in central nervous system (HP:0002529) | 1.99304120 |
| 104 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.98981202 |
| 105 | Hyporeflexia of lower limbs (HP:0002600) | 1.98890257 |
| 106 | Axonal loss (HP:0003447) | 1.98412402 |
| 107 | Scapular winging (HP:0003691) | 1.97770965 |
| 108 | Fragile nails (HP:0001808) | 1.96352982 |
| 109 | Deformed tarsal bones (HP:0008119) | 1.94307153 |
| 110 | Adactyly (HP:0009776) | 1.93682985 |
| 111 | Cholecystitis (HP:0001082) | 1.93319240 |
| 112 | Abnormal gallbladder physiology (HP:0012438) | 1.93319240 |
| 113 | Supranuclear gaze palsy (HP:0000605) | 1.93101074 |
| 114 | Diminished motivation (HP:0000745) | 1.92419466 |
| 115 | Nausea (HP:0002018) | 1.92107433 |
| 116 | Abnormal pupillary function (HP:0007686) | 1.90055508 |
| 117 | Abnormality of macrophages (HP:0004311) | 1.88917056 |
| 118 | Mucopolysacchariduria (HP:0008155) | 1.88152100 |
| 119 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.88152100 |
| 120 | Autoimmune thrombocytopenia (HP:0001973) | 1.87865533 |
| 121 | Cholelithiasis (HP:0001081) | 1.87617948 |
| 122 | Ulnar deviation of the wrist (HP:0003049) | 1.87391399 |
| 123 | Hemorrhage of the eye (HP:0011885) | 1.86851016 |
| 124 | Joint swelling (HP:0001386) | 1.86794018 |
| 125 | Increased CSF protein (HP:0002922) | 1.84293162 |
| 126 | Tetraparesis (HP:0002273) | 1.83789513 |
| 127 | Vertigo (HP:0002321) | 1.82232169 |
| 128 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.81409276 |
| 129 | Hypochromic microcytic anemia (HP:0004840) | 1.79096861 |
| 130 | Clumsiness (HP:0002312) | 1.78935456 |
| 131 | Hematochezia (HP:0002573) | 1.78533550 |
| 132 | Dysautonomia (HP:0002459) | 1.76596942 |
| 133 | Calf muscle hypertrophy (HP:0008981) | 1.75217486 |
| 134 | Bone pain (HP:0002653) | 1.74739321 |
| 135 | Glomerulonephritis (HP:0000099) | 1.74183719 |
| 136 | Basal ganglia calcification (HP:0002135) | 1.73564907 |
| 137 | Urticaria (HP:0001025) | 1.73485319 |
| 138 | Absent hand (HP:0004050) | 1.72648503 |
| 139 | Joint hemorrhage (HP:0005261) | 1.70341792 |
| 140 | Osteolytic defects of the hand bones (HP:0009699) | 1.70114501 |
| 141 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.70114501 |
| 142 | EMG: myopathic abnormalities (HP:0003458) | 1.69697297 |
| 143 | Dementia (HP:0000726) | 1.69308321 |
| 144 | Cerebral aneurysm (HP:0004944) | 1.68590490 |
| 145 | Abnormal gallbladder morphology (HP:0012437) | 1.68419891 |
| 146 | Aortic dissection (HP:0002647) | 1.67389367 |
| 147 | Mediastinal lymphadenopathy (HP:0100721) | 1.66827756 |
| 148 | Lower limb amyotrophy (HP:0007210) | 1.66683766 |
| 149 | Achilles tendon contracture (HP:0001771) | 1.66664178 |
| 150 | J-shaped sella turcica (HP:0002680) | 1.66596573 |
| 151 | Dyschromatopsia (HP:0007641) | 1.66277850 |
| 152 | Arterial thrombosis (HP:0004420) | 1.65998822 |
| 153 | Increased variability in muscle fiber diameter (HP:0003557) | 1.65231009 |
| 154 | Recurrent bacterial skin infections (HP:0005406) | 1.63735536 |
| 155 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.61025622 |
| 156 | Megalencephaly (HP:0001355) | 1.60984761 |
| 157 | Fragile skin (HP:0001030) | 1.60563612 |
| 158 | Parakeratosis (HP:0001036) | 1.59731836 |
| 159 | Increased density of long bones (HP:0006392) | 1.58462282 |
| 160 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.58169878 |
| 161 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.58169878 |
| 162 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.58169878 |
| 163 | Vertebral compression fractures (HP:0002953) | 1.57515816 |
| 164 | Onion bulb formation (HP:0003383) | 1.56955489 |
| 165 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.55906715 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHB1 | 3.46627813 |
| 2 | KDR | 3.44605452 |
| 3 | FGR | 2.77158365 |
| 4 | TAOK2 | 2.67684274 |
| 5 | TBK1 | 2.66291708 |
| 6 | ARAF | 2.50969920 |
| 7 | TRIB3 | 2.22818142 |
| 8 | LMTK2 | 2.15720800 |
| 9 | NME2 | 2.08985772 |
| 10 | EEF2K | 2.08559641 |
| 11 | EIF2AK1 | 2.07585370 |
| 12 | BMX | 2.04302689 |
| 13 | MAPKAPK5 | 2.02550542 |
| 14 | DDR2 | 1.97821878 |
| 15 | PHKG2 | 1.86916321 |
| 16 | PHKG1 | 1.86916321 |
| 17 | TRPM7 | 1.73113087 |
| 18 | MST4 | 1.64392809 |
| 19 | MAP3K11 | 1.59850402 |
| 20 | PRPF4B | 1.58706317 |
| 21 | TGFBR2 | 1.57794215 |
| 22 | RIPK1 | 1.53822687 |
| 23 | CSF1R | 1.53563940 |
| 24 | MAP2K2 | 1.53308890 |
| 25 | IKBKE | 1.51157921 |
| 26 | TTN | 1.48442823 |
| 27 | MAPK15 | 1.46405443 |
| 28 | CSK | 1.45823523 |
| 29 | PIM2 | 1.44253430 |
| 30 | ICK | 1.41816827 |
| 31 | TYRO3 | 1.39285110 |
| 32 | ABL2 | 1.38833865 |
| 33 | CAMK1G | 1.37543126 |
| 34 | FES | 1.33471051 |
| 35 | BMPR2 | 1.33322426 |
| 36 | GRK5 | 1.33319090 |
| 37 | MAP3K14 | 1.30725001 |
| 38 | IRAK4 | 1.30454938 |
| 39 | STK10 | 1.29743287 |
| 40 | GRK7 | 1.27423969 |
| 41 | EPHA2 | 1.25971384 |
| 42 | SYK | 1.23333013 |
| 43 | MATK | 1.22871905 |
| 44 | DMPK | 1.19025075 |
| 45 | NTRK2 | 1.15138464 |
| 46 | MYLK | 1.13778620 |
| 47 | TAOK1 | 1.12660458 |
| 48 | BTK | 1.12617990 |
| 49 | ERN1 | 1.12058140 |
| 50 | ADRBK2 | 1.11235486 |
| 51 | DYRK1B | 1.10751525 |
| 52 | TEC | 1.08327159 |
| 53 | IRAK1 | 1.05388216 |
| 54 | IKBKB | 1.02340390 |
| 55 | GRK6 | 1.02179947 |
| 56 | MUSK | 1.00920996 |
| 57 | SIK1 | 1.00394902 |
| 58 | KSR2 | 0.98585237 |
| 59 | MAPK12 | 0.97855093 |
| 60 | IRAK3 | 0.97456979 |
| 61 | TYK2 | 0.95866567 |
| 62 | LRRK2 | 0.95382143 |
| 63 | CDC42BPA | 0.94589830 |
| 64 | BLK | 0.94309690 |
| 65 | ILK | 0.92519493 |
| 66 | LATS2 | 0.91663178 |
| 67 | EPHA3 | 0.91659230 |
| 68 | MAP3K10 | 0.90781142 |
| 69 | MAPKAPK3 | 0.90490915 |
| 70 | TESK1 | 0.88780695 |
| 71 | TESK2 | 0.88190503 |
| 72 | MAP3K3 | 0.87610360 |
| 73 | PDGFRA | 0.86307390 |
| 74 | PTK2B | 0.84838199 |
| 75 | IRAK2 | 0.83127689 |
| 76 | JAK1 | 0.81428670 |
| 77 | MAP3K9 | 0.81333694 |
| 78 | PAK1 | 0.80835827 |
| 79 | PRKAA2 | 0.80772431 |
| 80 | PIM1 | 0.80460541 |
| 81 | MAP3K5 | 0.79756657 |
| 82 | PAK4 | 0.79555142 |
| 83 | NTRK1 | 0.78422068 |
| 84 | DAPK2 | 0.77343880 |
| 85 | PDPK1 | 0.77130403 |
| 86 | STK39 | 0.76751162 |
| 87 | PNCK | 0.75702839 |
| 88 | DAPK3 | 0.75155717 |
| 89 | MAP2K3 | 0.74585003 |
| 90 | MAP3K1 | 0.74331322 |
| 91 | MET | 0.72394632 |
| 92 | MAP4K1 | 0.72271956 |
| 93 | MOS | 0.71301777 |
| 94 | WNK1 | 0.71277168 |
| 95 | TAOK3 | 0.69598148 |
| 96 | PTK6 | 0.68813839 |
| 97 | PRKG2 | 0.68691898 |
| 98 | GSK3A | 0.68371549 |
| 99 | PKN1 | 0.68246527 |
| 100 | TNK2 | 0.68012850 |
| 101 | BRAF | 0.67966030 |
| 102 | PDGFRB | 0.66514713 |
| 103 | MAP2K1 | 0.66346902 |
| 104 | UHMK1 | 0.64229387 |
| 105 | PDK1 | 0.62388290 |
| 106 | ALK | 0.62087444 |
| 107 | JAK3 | 0.61251592 |
| 108 | JAK2 | 0.59358550 |
| 109 | ZAP70 | 0.58787258 |
| 110 | MAPKAPK2 | 0.58492845 |
| 111 | RIPK4 | 0.58120172 |
| 112 | HCK | 0.58022218 |
| 113 | OBSCN | 0.57895034 |
| 114 | CAMK2G | 0.57724312 |
| 115 | SIK3 | 0.57167874 |
| 116 | LCK | 0.56671421 |
| 117 | LYN | 0.55590282 |
| 118 | CLK1 | 0.55490038 |
| 119 | EGFR | 0.53388003 |
| 120 | PTK2 | 0.52655301 |
| 121 | MST1R | 0.51117262 |
| 122 | ROCK2 | 0.49717830 |
| 123 | PRKD1 | 0.48402324 |
| 124 | FYN | 0.46438402 |
| 125 | MARK3 | 0.44793899 |
| 126 | CDK14 | 0.44198564 |
| 127 | HIPK2 | 0.43960350 |
| 128 | ITK | 0.43383137 |
| 129 | MAPK11 | 0.42904229 |
| 130 | EPHB2 | 0.42879366 |
| 131 | PBK | 0.42806804 |
| 132 | MAP3K2 | 0.42155408 |
| 133 | CHUK | 0.42037645 |
| 134 | CAMKK2 | 0.41404704 |
| 135 | RPS6KA5 | 0.41166316 |
| 136 | NME1 | 0.40944211 |
| 137 | PLK2 | 0.40613339 |
| 138 | PINK1 | 0.38938020 |
| 139 | TXK | 0.38268400 |
| 140 | RPS6KA1 | 0.38120185 |
| 141 | MARK2 | 0.36165944 |
| 142 | RET | 0.35829458 |
| 143 | PKN2 | 0.34287416 |
| 144 | FLT3 | 0.31236062 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.85496113 |
| 2 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.14869329 |
| 3 | Malaria_Homo sapiens_hsa05144 | 2.05542903 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.00597465 |
| 5 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.86138628 |
| 6 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.74117177 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.73105097 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 1.69237440 |
| 9 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.63940928 |
| 10 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.60464379 |
| 11 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.48882705 |
| 12 | Viral myocarditis_Homo sapiens_hsa05416 | 1.46911393 |
| 13 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.42888877 |
| 14 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.41813117 |
| 15 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.39305834 |
| 16 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.34971871 |
| 17 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.33367073 |
| 18 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.33183303 |
| 19 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.31506233 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.30718905 |
| 21 | Pertussis_Homo sapiens_hsa05133 | 1.30689009 |
| 22 | Legionellosis_Homo sapiens_hsa05134 | 1.30546041 |
| 23 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.28968195 |
| 24 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.25066594 |
| 25 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.23183268 |
| 26 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.20387627 |
| 27 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.19274072 |
| 28 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.18412465 |
| 29 | Focal adhesion_Homo sapiens_hsa04510 | 1.18204346 |
| 30 | Galactose metabolism_Homo sapiens_hsa00052 | 1.17641998 |
| 31 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.15648122 |
| 32 | Shigellosis_Homo sapiens_hsa05131 | 1.15487477 |
| 33 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.14206845 |
| 34 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.12495828 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.11219169 |
| 36 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.09419898 |
| 37 | Lysosome_Homo sapiens_hsa04142 | 1.08945239 |
| 38 | Prion diseases_Homo sapiens_hsa05020 | 1.08554629 |
| 39 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.08143656 |
| 40 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.07685762 |
| 41 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.07519433 |
| 42 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.06942415 |
| 43 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.06907312 |
| 44 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.06298182 |
| 45 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.05760729 |
| 46 | Measles_Homo sapiens_hsa05162 | 1.04342270 |
| 47 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.04168244 |
| 48 | Salmonella infection_Homo sapiens_hsa05132 | 1.03754917 |
| 49 | Endocytosis_Homo sapiens_hsa04144 | 1.03633363 |
| 50 | Tuberculosis_Homo sapiens_hsa05152 | 1.01964564 |
| 51 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.01478789 |
| 52 | Apoptosis_Homo sapiens_hsa04210 | 1.01091194 |
| 53 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.00968055 |
| 54 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.99874733 |
| 55 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.99856636 |
| 56 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.99417774 |
| 57 | Amoebiasis_Homo sapiens_hsa05146 | 0.98522597 |
| 58 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.97769018 |
| 59 | Mineral absorption_Homo sapiens_hsa04978 | 0.96928261 |
| 60 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.96855146 |
| 61 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.95561268 |
| 62 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.94795326 |
| 63 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.94541609 |
| 64 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.92774984 |
| 65 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.92396114 |
| 66 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.92095069 |
| 67 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.91742952 |
| 68 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.91204759 |
| 69 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.90776568 |
| 70 | Platelet activation_Homo sapiens_hsa04611 | 0.89914236 |
| 71 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.89740046 |
| 72 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.89559381 |
| 73 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.88993923 |
| 74 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.88725810 |
| 75 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86653423 |
| 76 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.86299010 |
| 77 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.84822823 |
| 78 | Gap junction_Homo sapiens_hsa04540 | 0.84417953 |
| 79 | Bladder cancer_Homo sapiens_hsa05219 | 0.84099584 |
| 80 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.82876743 |
| 81 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.82825431 |
| 82 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.82525694 |
| 83 | Adherens junction_Homo sapiens_hsa04520 | 0.82133462 |
| 84 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.81622401 |
| 85 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.80620502 |
| 86 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.79490459 |
| 87 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.79190570 |
| 88 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.78754570 |
| 89 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.78256069 |
| 90 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.77388984 |
| 91 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.76565540 |
| 92 | Hepatitis B_Homo sapiens_hsa05161 | 0.75308479 |
| 93 | Long-term depression_Homo sapiens_hsa04730 | 0.74762602 |
| 94 | Glioma_Homo sapiens_hsa05214 | 0.74625615 |
| 95 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.73085374 |
| 96 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.73018867 |
| 97 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.71302962 |
| 98 | Tight junction_Homo sapiens_hsa04530 | 0.71210168 |
| 99 | Allograft rejection_Homo sapiens_hsa05330 | 0.71163643 |
| 100 | Asthma_Homo sapiens_hsa05310 | 0.71099455 |
| 101 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70634256 |
| 102 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.70218217 |
| 103 | Hepatitis C_Homo sapiens_hsa05160 | 0.68148343 |
| 104 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.67602254 |
| 105 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.67595692 |
| 106 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.67275069 |
| 107 | Circadian rhythm_Homo sapiens_hsa04710 | 0.66395576 |
| 108 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.66029454 |
| 109 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.65544146 |
| 110 | Influenza A_Homo sapiens_hsa05164 | 0.64597046 |
| 111 | Axon guidance_Homo sapiens_hsa04360 | 0.64381149 |
| 112 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.63352537 |
| 113 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.63193375 |
| 114 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.62150869 |
| 115 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.61894918 |
| 116 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.61674284 |
| 117 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.59557052 |
| 118 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.59444750 |
| 119 | Phagosome_Homo sapiens_hsa04145 | 0.59071078 |
| 120 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.58841339 |
| 121 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.58689282 |
| 122 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.58629898 |
| 123 | Insulin resistance_Homo sapiens_hsa04931 | 0.58606793 |
| 124 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.57213528 |
| 125 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.46948533 |
| 126 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.44848644 |
| 127 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.44722411 |
| 128 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.43842582 |

